Feature Channels:

Arthritis

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Early Infant Weight Gain, Preventing Vision Loss, Sesame Street's Julia, and More in the Children's Health News Source

Click here for the latest research and features on Children's Health.

Medicine

Channels:

Malaria Vaccine Trial, Sickle Cell and Kidney Failure, Zika and the Heart, and More in the Public Health News Source

The latest research, experts and features in Public Health in the Public Health News Source

Medicine

Channels:

Improving the ER, Opioids and Surgery, Colds in Transplant Patients, Hearing Aids, and More in the Healthcare News Source

The latest research, features and announcements in healthcare in the Healthcare News Source

Medicine

Channels:

repeal and replace, Healthcare Reform, american healthcare act, Healthcare, Health Care, Independent Payment Advisory Board, IPAB

ACR: AHCA Does Not Go Far Enough To Help Americans with Rheumatic Diseases

American College of Rheumatology President Sharad Lakhanpal, MBBS, MD, released a statement this morning expressing concern about the American Health Care Act's (AHCA) age-based tax credits and its failure to repeal the Independent Payment Advisory Board.

Medicine

Channels:

Aging, Kogod Center on Aging, Senescent cells, Senolytics

Mayo Clinic Researchers Uncover New Agents That Eliminate Cells Associated with Age-Related Diseases

Mayo Clinic researchers have uncovered three new agents to add to the emerging repertoire of drugs that aim to delay the onset of aging by targeting senescent cells – cells that contribute to frailty and other age-related conditions.

Medicine

Channels:

Rheumatoid Arthritis, RA, Rheumatoid Arthritis Remission, Rheumatoid Arthritis Medication, Autoantibodies, Autoimmune Disease And Disorder, B Cells, Tumor Necrosis Factor, anti-citrullinated protein antibodies, ACPA, Methotrexate

New Assay May Lead to a Cure for Debilitating Inflammatory Joint Disease

gregg-silverman-hero-crop.jpg

Current treatments for rheumatoid arthritis relieve the inflammation that leads to joint destruction, but the immunologic defect that triggers the inflammation persists to cause relapses. Now the results of a new study suggest that clinical trials for new rheumatoid arthritis (RA) drugs should shift from their sole focus on relieving inflammation to eliminating the B cells that produce these antibodies.

Medicine

Channels:

shoulder surgery, American Shoulder and Elbow Surgeons, elbow surgery, elbow replacement

Loyola Orthopaedic Surgeon Elected to American Shoulder and Elbow Surgeons

garbis-4734.jpg

Loyola Medicine orthopaedic surgeon Nickolas Garbis, MD, has been elected to the American Shoulder and Elbow Surgeons.

Medicine

Channels:

Chikungunya virus, Arthritis

Drug Combination Effective Against Chikungunya Arthritis in Mice

ArthriticHands.jpg

Chikungunya virus causes a painful, debilitating arthritis for which there is currently no treatment. A new study has found that combining a drug for rheumatoid arthritis with one that targets the chikungunya virus can eliminate the signs of arthritis in mice in the early stage of the disease.

Medicine

Channels:

boranes, borane, cancer diagnoses, Cancer Diagnosis, Cancer Treatment, alternative cancer therapies, Biomedical, Biomedical Agents, Biomedical And Health Research, Chemistry, Chemistry & Materials, Chemistry Nanotechnology/Micromachines Policy Ethics Technology Medicine Environment, Flourescence, Flourescence spectroscopy, Medical Image, Medical Imaging,

New Class of Materials Could Revolutionize Biomedical, Alternative Energy Industries

300x271_B12Ph9-40-90-144.gif

Polyhedral boranes have become the basis for the creation of cancer therapies, enhanced drug delivery and new contrast agents needed for radioimaging and diagnosis. Now, a researcher at the University of Missouri has discovered an entirely new class of materials based on boranes that might have widespread potential applications, including improved diagnostic tools for cancer and other diseases as well as low-cost solar energy cells.

Medicine

Channels:

Scripps Florida Team Awarded $1.8 Million Grant to Develop Drugs for Heart Disease and Rheumatoid Arthritis

roush_cropped.jpg

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded approximately $1.8 million from the National Institute of General Medical Sciences of the National Institutes of Health to develop a series of drug candidates for a number of diseases, including heart disease, rheumatoid arthritis and several neurodegenerative disorders.







Chat now!